Skip to main content
Top
Published in: Rheumatology International 3/2005

01-04-2005 | Case Report

Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behçet’s disease

Authors: Seung Woo Han, Gun Woo Kim, Jongmin Lee, Yong Joo Kim, Young Mo Kang

Published in: Rheumatology International | Issue 3/2005

Login to get access

Abstract

Budd-Chiari syndrome (BCS) is a very rare vascular complication of Behçet’s disease (BD) which often leads to death as a result of portal hypertension and liver failure. We report a 45-year-old BD patient who presented with BCS. Diagnosis was confirmed with CT scan and contrast-enhanced MR angiography which showed ascites, short-segment stenosis of the inferior vena cava (IVC), and middle and left hepatic venous thrombosis. Percutaneous transluminal angioplasty (PTA) of the obstructed segment in the IVC was performed and resulted in dramatic reduction of portal venous pressure. Our experience indicates that PTA may be a safe and effective therapeutic modality for BCS in BD which is caused by short segmental obstruction of the IVC.
Literature
1.
go back to reference Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological haemostasis and “prothrombotic state” in Behçet’s disease. Thromb Res 105:125–133CrossRefPubMed Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological haemostasis and “prothrombotic state” in Behçet’s disease. Thromb Res 105:125–133CrossRefPubMed
2.
go back to reference Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenterol 92:858–862PubMed Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenterol 92:858–862PubMed
3.
go back to reference Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8:223–260CrossRefPubMed Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8:223–260CrossRefPubMed
4.
go back to reference Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, Pichlmayr R (1995) Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 21:1337–1344CrossRefPubMed Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, Pichlmayr R (1995) Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 21:1337–1344CrossRefPubMed
5.
go back to reference Slakey DP, Klein AS, Venbrux AC, Cameron JL (2001) Budd-Chiari syndrome: current management options. Ann Surg 233:522–527CrossRefPubMed Slakey DP, Klein AS, Venbrux AC, Cameron JL (2001) Budd-Chiari syndrome: current management options. Ann Surg 233:522–527CrossRefPubMed
6.
go back to reference Pelage JP, Denys A, Valla D, Sibert A, Sauvanet A, Belghiti J, Menu Y (2003) Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol 13:286–293PubMed Pelage JP, Denys A, Valla D, Sibert A, Sauvanet A, Belghiti J, Menu Y (2003) Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol 13:286–293PubMed
7.
go back to reference Cakaloglu Y, Okten A, Yalcin S (1991) Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients. Gastroenterology 100:1484–1485PubMed Cakaloglu Y, Okten A, Yalcin S (1991) Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients. Gastroenterology 100:1484–1485PubMed
8.
go back to reference Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E (1999) Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44:568–574PubMed Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E (1999) Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44:568–574PubMed
9.
go back to reference Hendrick RE (1987) Sampling time effects on signal-to-noise and contrast-to-noise ratios in spin-echo MRI. Magn Reson Imaging 5:31–37CrossRefPubMed Hendrick RE (1987) Sampling time effects on signal-to-noise and contrast-to-noise ratios in spin-echo MRI. Magn Reson Imaging 5:31–37CrossRefPubMed
10.
go back to reference Wu T, Wang L, Xiao Q, Wang B, Li S, Li X, Zhang J (2002) Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 83:175–178CrossRefPubMed Wu T, Wang L, Xiao Q, Wang B, Li S, Li X, Zhang J (2002) Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 83:175–178CrossRefPubMed
11.
go back to reference Townsend (2001) Anatomy and development of liver. In: Sabiston textbook of surgery. Saunders, Phladelphia, pp 1002–1003 Townsend (2001) Anatomy and development of liver. In: Sabiston textbook of surgery. Saunders, Phladelphia, pp 1002–1003
12.
go back to reference O’Duffy JD (1990) Vasculitis in Behçet’s disease. Rheum Dis Clin North Am 16:423–431PubMed O’Duffy JD (1990) Vasculitis in Behçet’s disease. Rheum Dis Clin North Am 16:423–431PubMed
13.
go back to reference Ozoran K, Dugun N, Gurler A, Tutkak H, Tokgoz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet’s disease. Scand J Rheumatol 24:376–382PubMed Ozoran K, Dugun N, Gurler A, Tutkak H, Tokgoz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet’s disease. Scand J Rheumatol 24:376–382PubMed
14.
go back to reference Haznedaroglu IC, Ozdemir O, Ozcebe O, Dundar SV, Kirazli S (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet’s disease. Thromb Haemost 75:974–975PubMed Haznedaroglu IC, Ozdemir O, Ozcebe O, Dundar SV, Kirazli S (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet’s disease. Thromb Haemost 75:974–975PubMed
15.
go back to reference Aydintug AO, Tokgoz G, D’Cruz DP, Gurler A, Cervera R, Duzgun N, Atmaca LS, Khamashta MA, Hughes GR (1993) Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67:157–162CrossRefPubMed Aydintug AO, Tokgoz G, D’Cruz DP, Gurler A, Cervera R, Duzgun N, Atmaca LS, Khamashta MA, Hughes GR (1993) Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67:157–162CrossRefPubMed
Metadata
Title
Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behçet’s disease
Authors
Seung Woo Han
Gun Woo Kim
Jongmin Lee
Yong Joo Kim
Young Mo Kang
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0495-4

Other articles of this Issue 3/2005

Rheumatology International 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.